Placental mTOR Signaling and Sexual Dimorphism in Metabolic Health across the Lifespan of Offspring
- PMID: 34828683
- PMCID: PMC8619510
- DOI: 10.3390/children8110970
Placental mTOR Signaling and Sexual Dimorphism in Metabolic Health across the Lifespan of Offspring
Abstract
Robust evidence of fetal programming of adult disease has surfaced in the last several decades. Human and preclinical investigations of intrauterine insults report perturbations in placental nutrient sensing by the mechanistic target of rapamycin (mTOR). This review focuses on pregnancy complications associated with placental mTOR regulation, such as fetal growth restriction (FGR), fetal overgrowth, gestational diabetes mellitus (GDM), polycystic ovarian syndrome (PCOS), maternal nutrient restriction (MNR), preeclampsia (PE), maternal smoking, and related effects on offspring birthweight. The link between mTOR-associated birthweight outcomes and offspring metabolic health trajectory with a focus on sexual dimorphism are discussed. Both human physiology and animal models are summarized to facilitate in depth understanding. GDM, PCOS and fetal overgrowth are associated with increased placental mTOR, whereas FGR, MNR and maternal smoking are linked to decreased placental mTOR activity. Generally, birth weight is reduced in complications with decreased mTOR (i.e., FGR, MNR, maternal smoking) and higher with increased mTOR (GDM, PCOS). Offspring display obesity or a higher body mass index in childhood and adulthood, impaired glucose and insulin tolerance in adulthood, and deficiencies in pancreatic beta-cell mass and function compared to offspring from uncomplicated pregnancies. Defining causal players in the fetal programming of offspring metabolic health across the lifespan will aid in stopping the vicious cycle of obesity and type II diabetes.
Keywords: birth weight; fetal growth restriction; insulin sensitivity; mTOR signaling; obesity; placenta; pregnancy; type II diabetes.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
![Figure 1](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ec0/8619510/789872fca017/children-08-00970-g001.gif)
Similar articles
-
Placental mTOR complex 1 regulates fetal programming of obesity and insulin resistance in mice.JCI Insight. 2021 Jul 8;6(13):e149271. doi: 10.1172/jci.insight.149271. JCI Insight. 2021. PMID: 34032632 Free PMC article.
-
Exercise initiated during pregnancy in rats born growth restricted alters placental mTOR and nutrient transporter expression.J Physiol. 2019 Apr;597(7):1905-1918. doi: 10.1113/JP277227. Epub 2019 Mar 1. J Physiol. 2019. PMID: 30734290 Free PMC article.
-
Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus.Pediatrics. 2005 Mar;115(3):e290-6. doi: 10.1542/peds.2004-1808. Pediatrics. 2005. PMID: 15741354
-
Epigenetic modifications of placenta in women with gestational diabetes mellitus and their offspring.World J Diabetes. 2024 Mar 15;15(3):378-391. doi: 10.4239/wjd.v15.i3.378. World J Diabetes. 2024. PMID: 38591094 Free PMC article. Review.
-
Role of omega-3 polyunsaturated fatty acids in gestational diabetes, maternal and fetal insights: current use and future directions.J Matern Fetal Neonatal Med. 2021 Jan;34(1):124-136. doi: 10.1080/14767058.2019.1593361. Epub 2019 Mar 27. J Matern Fetal Neonatal Med. 2021. PMID: 30857450 Review.
Cited by
-
Impact of placental mTOR deficiency on peripheral insulin signaling in adult mice offspring.J Mol Endocrinol. 2023 Oct 18;71(4):e230035. doi: 10.1530/JME-23-0035. Print 2023 Nov 1. J Mol Endocrinol. 2023. PMID: 37855320 Free PMC article.
-
Maternal Exercise Prior to and during Gestation Induces Sex-Specific Alterations in the Mouse Placenta.Int J Mol Sci. 2023 Nov 17;24(22):16441. doi: 10.3390/ijms242216441. Int J Mol Sci. 2023. PMID: 38003633 Free PMC article.
-
STZ-induced gestational diabetes exposure alters PTEN/AKT/mTOR-mediated autophagy signaling pathway leading to increase the risk of neonatal hypoxic-ischemic encephalopathy.Reprod Toxicol. 2024 Jan;123:108494. doi: 10.1016/j.reprotox.2023.108494. Epub 2023 Oct 28. Reprod Toxicol. 2024. PMID: 38706688 Free PMC article.
-
RISING STARS: Mechanistic insights into maternal-fetal cross talk and islet beta-cell development.J Endocrinol. 2023 Nov 8;259(3):e230069. doi: 10.1530/JOE-23-0069. Print 2023 Dec 1. J Endocrinol. 2023. PMID: 37855321 Free PMC article. Review.
-
Sex Differences in Pancreatic β-Cell Physiology and Glucose Homeostasis in C57BL/6J Mice.J Endocr Soc. 2023 Jul 25;7(9):bvad099. doi: 10.1210/jendso/bvad099. eCollection 2023 Aug 2. J Endocr Soc. 2023. PMID: 37873500 Free PMC article.
References
-
- Agarwal P., Morriseau T.S., Kereliuk S.M., Doucette C.A., Wicklow B.A., Dolinsky V.W. Maternal obesity, diabetes during pregnancy and epigenetic mechanisms that influence the developmental origins of cardiometabolic disease in the offspring. Crit. Rev. Clin. Lab. Sci. 2018;55:71–101. doi: 10.1080/10408363.2017.1422109. - DOI - PubMed
-
- Rosario F.J., Gupta M.B., Myatt L., Powell T.L., Glenn J.P., Cox L., Jansson T. Mechanistic Target of Rapamycin Complex 1 Promotes the Expression of Genes Encoding Electron Transport Chain Proteins and Stimulates Oxidative Phosphorylation in Primary Human Trophoblast Cells by Regulating Mitochondrial Biogenesis. Sci. Rep. 2019;9:1–14. doi: 10.1038/s41598-018-36265-8. - DOI - PMC - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous